Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women [Phase 4]

View source ↗

Summary

Phase 4 trial assessing immunogenicity and safety of Boostrix vaccine in pregnant women has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria-Tetanus-acellular Pertussis Vaccines | Phase 4 | Status: COMPLETED | Results posted: 2019-01-28